This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Studies like SPARK highlight the importance of human data in accelerating patient-facing research. Want to learn more about translational research?
In recent years, a novel approach known as condensate biology has emerged, revolutionising the way researchers think about drug discovery and development. Trained as a physician scientist, he obtained his MD/PhD from Cornell Rockefeller and Sloan Kettering, specialising in Immunology, Genetics, and Cancer Biology.
He suggests that peer review doesn’t “do the thing it’s supposed to do” — namely, “catch bad research and prevent it from being published,” so perhaps scientists would be better off uploading PDFs to the internet where review and oversight can happen post-publication.
Controlling the amount of RNP entering each cell is challenging, leading to uncertainty about the ratio of RNP that reaches any specific cell. Importantly for the researcher, there is no assurance that the RNP, once inside the cells, will reliably enter their nuclei.
Controlling the amount of RNP entering each cell is challenging, leading to uncertainty about the ratio of RNP that reaches any specific cell. Importantly for the researcher, there is no assurance that the RNP, once inside the cells, will reliably enter their nuclei.
Turning this tide, Professor Jens Christian Schwamborn, a cellbiology expert at the University of Luxembourg and co-founder of OrganoTherapeutics , is leading a groundbreaking effort to transform our understanding and treatment of these debilitating diseases. Schwamborns research focuses on creating patient-specific brain organoids.
Chinese researchers scoured ancient medical texts containing written records of malaria outbreaks and the plant-derived recipes that were used to treat them nearly two thousand years ago. Over the course of 12 years, the Walter Reed Army Institute of Research (WRAIR) screened more than 250,000 compounds in search of an efficacious treatment.
After the corresponding transfection or treatment with inhibitor of catenin-responsive transcription-3 (iCRT-3), abovementioned CRC cell biological behaviors as well as expression levels of HOXB7 and β-catenin were evaluated. μM THA dwindled CRC cell viability, migration, and invasion, and facilitated apoptosis.
Shortly after finishing my studies, I landed my first job in industry working on cellbiologyresearch for several disease indications. Mentors are essential for growth, especially as they provided a trusted resource to help navigate new research frontiers and obstacles.
DDP-resistant NPC cells were established by treatment with DDP at increased concentrations (2, 4, 6, 8, or 10 μg/mL). Cell biological behaviors were assessed via cell function experiments. MicroRNA-577 and EIF5A2 mRNA expressions were detected by qRT-PCR.
Researchers at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive Cancer Center have uncovered a new role of a chromatin-modulatory enzyme, termed EZH2, during cancer development. Their findings are published online in Nature CellBiology.
A recently published study 1 from a large team of cell biologists sheds new light on cellular organisation and variability. Can you give a brief overview of your research methods? SR: This project started in the early days of the Allen Institute for Cell Science, nearly seven years ago.
Findings published in the leading peer-reviewed oncology journal, Breast Cancer Research [ 3 ], showed a strong correlation between several imaging features and clinicopathological characteristics. Breast Cancer Research (2020) 22:42. This article first appeared on MDLinx.
Accessed on 1 December 2020.
As researchers increased their ability to gather large amounts of genetic data, they gained the ability to study the genome as a whole, giving rise to the field of genomics. This article aims to provide an overview rather than an exhaustive summary of the topic; interested readers may wish to dive deeper into the included references.
This is the first article in our new column. The researchers measured the fluorescence of each nucleus using a device called a flow cytometer, and found that samples from the New Caledonian fork fern were about 9-times brighter than those from an onion. These are pieces that are too short to run in our quarterly Issues.
This is Codon Digest, a weekly roundup of research papers, news articles, and industry highlights about engineered biology. ” — Samuel Butler , 1878 (* = My picks) AI + Bio Characterizing the interaction conformation between T-cell receptors and epitopes with deep learning. Nucleic Acids Research.
This is Codon Digest, my weekly roundup of research, news, and industry highlights about the future of biology. Nucleic Acids Research. Nature CellBiology. Nucleic Acids Research. Read Truncated CD19 as a selection marker for the isolation of stem cell derived β-cells. Nature Methods.
This study sheds light on how, exactly, AI-generated text differs from the real stuff, and how it could be used to (soon) write entire research papers. Read Stem cells were induced to form insulin-secreting pancreas cells and then transplanted into diabetic mice, where they successfully restored glucose levels.
This study sheds light on how, exactly, AI-generated text differs from the real stuff, and how it could be used to (soon) write entire research papers. Read Stem cells were induced to form insulin-secreting pancreas cells and then transplanted into diabetic mice, where they successfully restored glucose levels.
Today, we’re launching Issue 04 with this essay about the future of fertility and in vitro oogenesis — a technology that could soon be used to convert human skin cells into eggs or sperm — by one of its foremost developers. Thanks for reading. This multi-month method matches the duration of germline commitment in vivo.
After undergraduate studies with Dr. J Allan Hobson at Harvard, he was a student of Dr. Masao Ito at the University Tokyo (MPH) and Fulbright fellow with Dr. Wolf Singer at the Max-Planck Institute for Brain Research, prior to receiving a Ph.D. Conte Center for Basic Mental Health Research at Harvard. He received his Ph.D.
Codon Digest is my weekly roundup of research, news, and industry highlights about engineered biology. AI + Bio *Emergent autonomous scientific research capabilities of large language models. Read There’s a news article that breaks down this work. Nature CellBiology. Please send me your feedback.
Co-founder and CEO Dr Dan Williams brings over 20 years of experience in biochemistry and drug development, with a strong background in research and clinical trials. After earning a degree in biochemistry and physiology, followed by a PhD from the University of Dundee, Williams built a diverse career in research and drug development.
3 Antibodies are primarily used to target extracellular proteins, though researchers have generated antibodies that can reach intracellular targets. However, it remains challenging to design antibodies that cross cell membranes. Ajay N Jain Ajay is VP of Research for the Optibrium s BioPharmics Division. Goto Y, Suga H.
She has a background in cellbiology, biophysics and pharmacology and was a professor and Chair at the University of Kansas for over 20 years. He completed a research fellowship and his residency in plastic surgery. Lisa is a fellow in the American Institute of Medical and Biological Engineering.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content